第四军医大学学报
第四軍醫大學學報
제사군의대학학보
JOURNAL OF THE FOURTH MILITARY MEDICAL UNIVERSITY
2001年
11期
1029-1032
,共4页
卵巢切除术%骨质疏松%选择性雌激素受体调节剂%他莫昔芬%骨密度
卵巢切除術%骨質疏鬆%選擇性雌激素受體調節劑%他莫昔芬%骨密度
란소절제술%골질소송%선택성자격소수체조절제%타막석분%골밀도
目的选择性雌激素受体调节剂对去势大鼠松质骨、皮质骨骨密度的影响. 方法将21只SD大鼠随机分为3组,每组7只,A组为对照组,B组为去势组,C组为去势+他莫昔芬组,在去势后5 wk给药. 术后16 wk处死各组大鼠,进行离体骨密度(bone mineral density, BMD)测量及组织形态学测量. 结果①与对照组相比,去势组去势后16 wk股骨头、股骨颈、股骨干、肱骨头、肱骨干、腰椎BMD明显降低(P<0.01); 骨小梁体积、骨小梁厚度、椎体皮质骨厚度、结连结密度、结密度亦明显降低(P<0.05)而游离端密度和结连游离端密度增高(P<0.01);②他莫昔芬治疗后11 wk,各部位BMD增加(P<0.05)但没有恢复到正常水平(P<0.05);腰椎骨小梁连接性参数恢复到对照组水平(P>0.05). 结论①去势后16 wk大鼠松质骨、皮质骨骨量均明显下降,腰椎骨小梁三维结构破坏,骨小梁连结程度降低;②他莫昔芬治疗后,松质骨、皮质骨骨量均明显增加,但没有恢复到去势前水平;③他莫昔芬能增加腰椎椎体皮质骨厚度,增加腰椎骨小梁厚度. 增加皮质骨、松质骨骨量;还可提高腰椎微构筑的质量,使骨小梁连结程度增加.
目的選擇性雌激素受體調節劑對去勢大鼠鬆質骨、皮質骨骨密度的影響. 方法將21隻SD大鼠隨機分為3組,每組7隻,A組為對照組,B組為去勢組,C組為去勢+他莫昔芬組,在去勢後5 wk給藥. 術後16 wk處死各組大鼠,進行離體骨密度(bone mineral density, BMD)測量及組織形態學測量. 結果①與對照組相比,去勢組去勢後16 wk股骨頭、股骨頸、股骨榦、肱骨頭、肱骨榦、腰椎BMD明顯降低(P<0.01); 骨小樑體積、骨小樑厚度、椎體皮質骨厚度、結連結密度、結密度亦明顯降低(P<0.05)而遊離耑密度和結連遊離耑密度增高(P<0.01);②他莫昔芬治療後11 wk,各部位BMD增加(P<0.05)但沒有恢複到正常水平(P<0.05);腰椎骨小樑連接性參數恢複到對照組水平(P>0.05). 結論①去勢後16 wk大鼠鬆質骨、皮質骨骨量均明顯下降,腰椎骨小樑三維結構破壞,骨小樑連結程度降低;②他莫昔芬治療後,鬆質骨、皮質骨骨量均明顯增加,但沒有恢複到去勢前水平;③他莫昔芬能增加腰椎椎體皮質骨厚度,增加腰椎骨小樑厚度. 增加皮質骨、鬆質骨骨量;還可提高腰椎微構築的質量,使骨小樑連結程度增加.
목적선택성자격소수체조절제대거세대서송질골、피질골골밀도적영향. 방법장21지SD대서수궤분위3조,매조7지,A조위대조조,B조위거세조,C조위거세+타막석분조,재거세후5 wk급약. 술후16 wk처사각조대서,진행리체골밀도(bone mineral density, BMD)측량급조직형태학측량. 결과①여대조조상비,거세조거세후16 wk고골두、고골경、고골간、굉골두、굉골간、요추BMD명현강저(P<0.01); 골소량체적、골소량후도、추체피질골후도、결련결밀도、결밀도역명현강저(P<0.05)이유리단밀도화결련유리단밀도증고(P<0.01);②타막석분치료후11 wk,각부위BMD증가(P<0.05)단몰유회복도정상수평(P<0.05);요추골소량련접성삼수회복도대조조수평(P>0.05). 결론①거세후16 wk대서송질골、피질골골량균명현하강,요추골소량삼유결구파배,골소량련결정도강저;②타막석분치료후,송질골、피질골골량균명현증가,단몰유회복도거세전수평;③타막석분능증가요추추체피질골후도,증가요추골소량후도. 증가피질골、송질골골량;환가제고요추미구축적질량,사골소량련결정도증가.
AIM To discuss the influence of selective estrogen receptor modulator (SERM) on bone mineral density loss in cancellated bone and compact bone of ovariectomized rats. METHODS Twenty-one female SD rats were divided into three groups (7 rats per group). Bilateral ovariectomies were done on group B and C. Sham operation was done on group A. Group C was treated with tamoxifen 5 weeks later. Sixteen weeks after operation, all rats were sacrificed. BMD of L1-L5 vertebrae, femoral head, femoral neck, femoral body, humeral head and humeral body were measured by dual energy x-ray absorptiometry (DEXA), and L2 Vertebrae were for histomorphometric analysis. RESULTS ① Sixteen weeks after ovariectomy, BMD of L1-L5 vertebrae, femoral head, femoral neck, femoral body, humeral head, humeral body decreased significantly (P<0.01), while the density of free endpoints and free-notes struts increased significantly (P<0.01) as compared with sham group. The trabecular became thiner and irregular which changed the bone microstructure in three dimensions. ② After treatment of tamoxifen, the above parameters restored (P<0.05), but not to the level of sham group (P>0.05). CONCLUSION ① Ovariectomy may induce significant decrease of cancellated bone mass and compacts bone mass. ② Treatment tamoxifen could inhibit bone loss, but the bone mass couldn't restore to the level of sham group.